ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate Daratumumab in Transplant Eligible Participants With Previously Untreated Multiple Myeloma (Cassiopeia)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02541383
Recruitment Status : Active, not recruiting
First Posted : September 4, 2015
Last Update Posted : August 24, 2018
Sponsor:
Collaborators:
HOVON - Dutch Haemato-Oncology Association
Janssen Research & Development, LLC
Information provided by (Responsible Party):
Intergroupe Francophone du Myelome

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : August 2022
  Estimated Study Completion Date : August 2024